Human papillomavirus G-rich regions as potential antiviral drug 1 targets - Archive ouverte HAL Access content directly
Journal Articles Nucleic Acid Therapeutics Year : 2020

Human papillomavirus G-rich regions as potential antiviral drug 1 targets

(1) , (1) , (2) , (2) , (3) , (3) , (4, 5, 6) , (4) , (1) , (1)
1
2
3
4
5
6

Abstract

Herein we report for the first time the screening of several ligands in terms of their ability to bind and stabilize G-quadruplexes found in seven human Papillomavirus (HPV) genomes. Using a variety of biophysical assays, HPV G-quadruplexes were shown to possess a high degree of structural polymorphism upon ligand binding which may have an impact on transcription, replication and viral protein production. A sequence found in high-risk HPV16 genotype folds into multiple non-canonical DNA structures; it was converted into a major G-quadruplex conformation upon interaction with a well-characterized highly selective G4-ligand, PhenDC3, which may have animpact on the viral infection. Likewise, HPV57 and 58, which fold into multiple G-quadruplex structures, were found to form single stable complexes in the presence of two other G4-ligands, C8and Pyridostatin, respectively. Additionally, one of the selected compounds, the acridine derivative C8, demonstrated a significant antiviral effect in HPV18-infected organotypic raft cultures. Altogether, these results indicate that targeting HPV G-quadruplexes may be an alternative route for the development of novel antiviral therapies.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02958829 , version 1 (06-10-2020)

Identifiers

  • HAL Id : inserm-02958829 , version 1

Cite

Josué Carvalho, Jéssica Lopes-Nunes, Maria P C Campello, António Paulo, Janice Milici, et al.. Human papillomavirus G-rich regions as potential antiviral drug 1 targets. Nucleic Acid Therapeutics, inPress. ⟨inserm-02958829⟩
89 View
3 Download

Share

Gmail Facebook Twitter LinkedIn More